0775:HKG
CK Life Sciences Intl (Holdings) Inc
HK$0.51
0.00%
(0.00) 1D
Oct 16, 4:08:14 PM GMT+8 · HKD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 0775...
Open
HK$0.51
High
HK$0.52
Low
HK$0.51
Mkt. cap
4.90B
Avg. vol.
1.66M
Volume
956.00K
52-wk high
HK$1.02
52-wk low
HK$0.51
EPS
-HK$0.01
Shares outstanding
9.61B
No. of employees
2K
Open
HK$0.51
High
HK$0.52
Low
HK$0.51
Mkt. cap
4.90B
Avg. vol.
1.66M
Volume
956.00K
52-wk high
HK$1.02
52-wk low
HK$0.51
EPS
-HK$0.01
Shares outstanding
9.61B
No. of employees
2K
News stories
From web sources and news partners
FOREX.com
·
26 minutes ago
S&P 500, Nasdaq, Dow and Russell 2000 For the Week Ahead
Yahoo Finance
·
4 hours ago
Iambic Therapeutics (IAM) Joins The Nasdaq Composite, Is The Stock Already Pricey?
ETF Database
·
1 day ago
S&P 500 Snapshot: Stocks Slide Nearly 2% for the Week
디지털투데이
·
5 hours ago
Bitcoin could fall to $10,000 if S&P 500 drops 20 percent - Bloomberg
Profile
CK Life Sciences International Inc., or CK Life Sciences, is a subsidiary of CK Hutchison Holdings. It is engaged in research and development, commercialization, marketing and sale of biotechnology products. The chairman is Victor Li Tzar-kuoi, the eldest son of Li Ka-shing, the chairman of Cheung Kong Holdings.
It was established in 2000 and listed on the Hong Kong Stock Exchange via Growth Enterprise Market in 2002. It was transferred to Main Board of the Hong Kong Stock Exchange in 2008.
CK Life Sciences has operations in Australia, and in 2012 acquired an Australian salt company as part of its expansion into the agricultural sector.
The company divested its Canadian subsidiary WEX Pharmaceuticals to Virios Therapeutics for $100 million in October 2024. Wikipedia
About CK Life Sciences Intl (Holdings) Inc